Table 5.
Mean and standard deviation values for thermographic according to groups and evaluations
| Thermographic | Group | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| 3rd | 21.09 ± 1.74 | 20.23 ± 0.91 | 22.80 ± 0.82 | 23.03 ± 0.68 | 23.66 ± 0.39 | 24.30 ± 0.41 | 23.13 ± 1.25 |
| 7th | 22.24 ± 1.92 | 21.20 ± 0.88 | 23.43 ± 0.81 | 23.98 ± 1.05 | 24.25 ± 0.63 | 25.45 ± 0.56 | 24.39 ± 1.49 |
| 14th | 22.57 ± 1.25 | 22.54 ± 0.67 | 22.49 ± 1.01 | 22.85 ± 0.70 | 23.66 ± 0.86 | 24.45 ± 0.86 | 24.17 ± 0.55 |
| 21st | 21.12 ± 0.50 | 23.22 ± 0.64 | 21.99 ± 0.85 | 22.65 ± 1.05 | 23.00 ± 0.69 | 21.89 ± 0.35 | 23.99 ± 0.86 |
Group 1: control (placebo), Group 2: photobiomodulation (PBM) applied to the paw with complex regional pain syndrome type I (CRPS-I) from the warm phase, Group 3: PBM applied to the paw with CRPS-I from the acute phase, Group 4: PBM applied close to the area of the region between L4 and L5 from the warm phase, Group 5: PBM applied close to the area of the region between L4 and L5 from the acute phase, Group 6: PBM applied at two points: right paw and region between L4 and L5 from the warm phase, Group 7: PBM applied at two points: right paw and region between L4 and L5 from the acute phase, 3rd: third evaluation day, 7th: seventh evaluation day, 14th: fourteenth evaluation day, 21st: twenty-first evaluation day.